Status:
RECRUITING
Oral Health Status of Cystic Fibrosis Patients. An Online Survey in Collaboration With the Vaincre la Mucoviscidose Patient Association.
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Vaincre la Mucoviscidose
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
Cystic Fibrosis (CF) is a rare hereditary disease with autosomal recessive transmission, affecting 1 in 4700 births in France. Numerous studies have explored the links between oral health and CF, pred...
Detailed Description
Cystic Fibrosis (CF) is a rare hereditary disease with autosomal recessive transmission, affecting 1 in 4700 births in France. It is characterized by a mutation in the CFTR gene (Cystic Fibrosis Trans...
Eligibility Criteria
Inclusion Criteria:
- Adult patient (> 18 years old)
- Cystic fibrosis patient
- Patient who speaks and understands French well enough to read and understand the study information leaflet.
- Patient does not object to participation in the study
Exclusion Criteria:
NA
Key Trial Info
Start Date :
April 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06356246
Start Date
April 30 2025
End Date
July 31 2025
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marjolaine GOSSET
Ivry-sur-Seine, Île-de-France Region, France, 94270